EUVIMEDEUVIMED entdecken
Fallbericht

Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate

Giulia Milano, Laura Banov, Johanna Svahn, Marco Gucciardo, Fernando Marotta, Angelo Claudio Molinari

Acta Haematologica · 2023

DOI: 10.1159/000529056 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Haematologica, 2023. Verfasst von Giulia Milano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy. Hauptthemen laut MEDLINE: Hemophilia B, Hemophilia A, Cardiac Surgical Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Successful management of surgery in severe coagulation disorders depends on adequate replacement of the deficient factors from intervention until wound healing. Extended half-life (EHL) recombinant factor IX (rFIX) has been increasingly used in hemophilia B (HB) patients. Monitoring of blood levels of EHL rFIX allows to obtain pharmacokinetic (PK) parameters in order to optimize and personalize therapeutic scheme. We describe a case of a young male with severe HB who successfully underwent aortic valve repair. This is the first reported open-heart surgery in a patient with severe HB using EHL rFIX. The success was based on accurate PK evaluation and on meticulous preoperative planning and close cooperation among surgeons, hemophilia specialists, and laboratory team despite the long distance between hemophilia center and surgical clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia BHemophilia ACardiac Surgical ProceduresHumansMaleFactor IXHalf-LifeAortic ValveBlood Coagulation Factors

Stichwörter der Autor:innen

Albutrepenonacog alfaCardiopulmonary bypassHemophilia BPharmacokinetics

Substanzen

Factor IXprothrombin complex concentratesBlood Coagulation Factors

Autor:innen und Institutionen

  • Laboratory Medicine, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.
  • Regional Reference Centre for Hemorrhagic Diseases, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Department of Cardiac Surgery, ICLAS, GVM Care and Research, Rapallo, Italy.
  • Laboratory Medicine, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Zitieren

APA

Milano, G., Banov, L., Svahn, J., Gucciardo, M., Marotta, F., & Molinari, A. C. (2023). Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate. Acta Haematologica. https://doi.org/10.1159/000529056

Vancouver

Milano G, Banov L, Svahn J, Gucciardo M, Marotta F, Molinari AC. Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate. Acta Haematologica. 2023. doi:10.1159/000529056

BibTeX
@article{Milano2023,
  author = {Milano, Giulia and Banov, Laura and Svahn, Johanna and Gucciardo, Marco and Marotta, Fernando and Molinari, Angelo Claudio},
  title = {Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate},
  journal = {Acta Haematologica},
  year = {2023},
  doi = {10.1159/000529056}
}
Kostenlos starten →